Diseases, Conditions, Syndromes

Dry eye disease often diagnosed in alopecia areata

(HealthDay)—Many patients with alopecia areata are diagnosed with dry eye disease (DED), and patients should be referred for an ophthalmic evaluation, according to a study published in the November issue of the International ...

Medications

FDA approves Litfulo for teens, adults with alopecia areata

The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.

Diseases, Conditions, Syndromes

Zinc levels may predict worse outcomes with alopecia

(HealthDay)—Lower serum zinc levels are associated with worse outcomes in patients with alopecia areata, according to a study published online July 3 in the International Journal of Dermatology.

Diseases, Conditions, Syndromes

Vitiligo, alopecia areata may up atopic dermatitis risk

(HealthDay)—The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to research published online Dec. 3 in JAMA Dermatology.

Diseases, Conditions, Syndromes

UVA-1 promising for patients with refractory alopecia areata

(HealthDay)—For patients with alopecia areata (AA), phototherapy with ultraviolet A-1 (UVA-1) is a promising treatment modality, according to a research letter published in the October issue of the International Journal ...

Diseases, Conditions, Syndromes

Arthritis drug may help with type of hair loss

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

page 2 from 4